{
  "pmcid": "12094288",
  "sha256": "c8fc0d9075c5d70fb17cda345febb39cf72f7a0d963319e0dad334eaf4968dca",
  "timestamp_utc": "2025-11-09T23:26:35.411609+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.638037232820043,
    "reading_ease": 18.751797287979798,
    "word_count": 229
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Perioperative Cardiovascular Risk Assessment"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was computer-generated"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were patients undergoing non-cardiac surgeries."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received the new guideline-based assessment, while the control group received standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effectiveness of a new guideline for perioperative CV risk assessment in reducing complications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of CV complications within 30 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was applied to outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in CV complications (mean difference = 5.2%, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the intervention group and 1% of the control group, with mild gastrointestinal side-effects."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Supported by the Brazilian Society of Cardiology."
      }
    },
    "total_score": 24,
    "max_score": 25
  }
}